Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin (TRIB, AXK, BLUD, VIVO)
Posted in: Markets, Trading Ideas
Below are the top small-cap diagnostic substance stocks on the NYSE, the NASDAQ and the AMEX in terms of profit margin.
The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 59.32%. TRIB's PEG ratio is 1.60.
The trailing-twelve-month profit margin at Accelr8 Technology Corporation (AMEX: AXK) is 41.57%. AXK's ROE for the same period is 26.45%.
The trailing-twelve-month profit margin at Immucor Inc (NASDAQ: BLUD) is 25.57%. BLUD's ROE for the same period is 18.07%.
The trailing-twelve-month profit margin at Meridian Bioscience Inc (NASDAQ: VIVO) is 18.63%. VIVO's PEG ratio is 1.85.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
